Global Digital Biology Market

Digital Biology Comprehensive Study by Type (Botany,, Conservation, , ecology,, Evolution,, Genetics,, Marine biology, , medicine,, Microbiology, molecular biology, physiology, and zoology.), Application (Anatomy, Associated fields), Drug Discovery & Disease Modelling (Target Identification, Target Validation, Lead Optimization, Others), Preclinical Drug Development (Pharmacokinetics, Pharmacodynamics), Platform (Open Source, Closed Source), Clinical trials (Phase I, Phase II, Phase III, Human Body Simulation Software) Players and Region - Global Market Outlook to 2028

Digital Biology Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Market Snapshot:
Digital Biology the study of the key calculation performed by natural cycles, from gene regulatory systems to environments and from neural organizations to swarming frameworks. The expanding measure of information that is being gained, put away, and prepared in the existence sciences and wellbeing area makes the advancement of new data innovations one of the critical elements for propelling the present status of information in biomedical and wellbeing research.

Highlights from Digital Biology Market Study
AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)


The key Players profiled in the report are DUNA Bioinformatics (Brazil), Precigen (Intrexon Corporation) (United States), Dassault Systèmes (France), Genedata AG (Switzerland) and Simulations Plus, Inc. (United States). Additionally, other players that are part of this comprehensive study are Genedata AG (Switzerland) and Simulations Plus, Inc. (United States).

Geographic Breakdown and Segment Analysis
The Global Digital Biology market presents a comprehensive analysis of the Digital Biology market by product type (botany,, conservation, , ecology,, evolution,, genetics,, marine biology, , medicine, and microbiology, molecular biology, physiology, and zoology.), by end-user/application (Anatomy and Associated fields), and by geography (North America, South America, Europe, Asia-Pacific and MEA) along with country level break-up. This section of our report presents a realistic picture of the Global Digital Biology industry. Investors and Players can easily understand the inherent opportunities and challenges for their products in geographical region of interest. For instance, while the holds majority of market share of the Digital Biology market

Analyst at AMA have segmented the market study of Global Digital Biology market by Type, Application and Region.

Influencing Trend:
Growing R&D Funding and Growing Initiatives in Digital Biology

Market Growth Drivers:
The rise in the demand for modified medicine is expected to propel the demand for advanced tools and Growing Investments in the Digital Biology Market

Challenges:
Capital investment and huge data storage

Restraints:
Lack of skilled professionals

Opportunities:
High demand within life sciences and the biopharma associations due to their need for streamlining R&D processes and reduce timelines & costs associated with drug discovery and development

Market Developments Activities:
May 4, 2022 – The global professional services firm ZS announced today that it has acquired Danish bioinformatics and systems biology company, Intomics. Founded in Copenhagen, Denmark in 2008, Intomics accelerates and optimizes pharmaceutical drug discovery and development by enabling complex analysis of biomedical data. The addition of renowned scientists to the ZS team will strengthen ZS’s focus on the discovery of new medicines for all.
In Oct 2023 The Faculty of Life Sciences & Medicine is excited to announce the launch of a new postgraduate master’s course for 2024 entry. The MSc in Applied Bioinformatics is open to graduates of life sciences and physical sciences who not only want to gain key skills to analyse, interpret and integrate biological data, but also understand how to apply these skills to research.



The companies are exploring the market by adopting expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations.

Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Digital Biology Researchers, Government Regulatory and Research Organizations and End-Use Industry

Report Objectives / Segmentation Covered

By Type
  • botany,
  • conservation
  • , ecology,
  • evolution,
  • genetics,
  • marine biology
  • , medicine,
  • microbiology, molecular biology, physiology, and zoology.
By Application
  • Anatomy
  • Associated fields
By Drug Discovery & Disease Modelling
  • Target Identification
  • Target Validation
  • Lead Optimization
  • Others

By Preclinical Drug Development
  • Pharmacokinetics
  • Pharmacodynamics

By Platform
  • Open Source
  • Closed Source

By Clinical trials
  • Phase I
  • Phase II
  • Phase III
  • Human Body Simulation Software

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The rise in the demand for modified medicine is expected to propel the demand for advanced tools
      • 3.2.2. Growing Investments in the Digital Biology Market
    • 3.3. Market Challenges
      • 3.3.1. Capital investment and huge data storage
    • 3.4. Market Trends
      • 3.4.1. Growing R&D Funding and Growing Initiatives in Digital Biology
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Digital Biology, by Type, Application, Drug Discovery & Disease Modelling, Preclinical Drug Development, Platform, Clinical trials and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Digital Biology (Value)
      • 5.2.1. Global Digital Biology by: Type (Value)
        • 5.2.1.1. Botany,
        • 5.2.1.2. Conservation
        • 5.2.1.3. , ecology,
        • 5.2.1.4. Evolution,
        • 5.2.1.5. Genetics,
        • 5.2.1.6. Marine biology
        • 5.2.1.7. , medicine,
        • 5.2.1.8. Microbiology, molecular biology, physiology, and zoology.
      • 5.2.2. Global Digital Biology by: Application (Value)
        • 5.2.2.1. Anatomy
        • 5.2.2.2. Associated fields
      • 5.2.3. Global Digital Biology by: Drug Discovery & Disease Modelling (Value)
        • 5.2.3.1. Target Identification
        • 5.2.3.2. Target Validation
        • 5.2.3.3. Lead Optimization
        • 5.2.3.4. Others
      • 5.2.4. Global Digital Biology by: Preclinical Drug Development (Value)
        • 5.2.4.1. Pharmacokinetics
        • 5.2.4.2. Pharmacodynamics
      • 5.2.5. Global Digital Biology by: Platform (Value)
        • 5.2.5.1. Open Source
        • 5.2.5.2. Closed Source
      • 5.2.6. Global Digital Biology by: Clinical trials (Value)
        • 5.2.6.1. Phase I
        • 5.2.6.2. Phase II
        • 5.2.6.3. Phase III
        • 5.2.6.4. Human Body Simulation Software
      • 5.2.7. Global Digital Biology Region
        • 5.2.7.1. South America
          • 5.2.7.1.1. Brazil
          • 5.2.7.1.2. Argentina
          • 5.2.7.1.3. Rest of South America
        • 5.2.7.2. Asia Pacific
          • 5.2.7.2.1. China
          • 5.2.7.2.2. Japan
          • 5.2.7.2.3. India
          • 5.2.7.2.4. South Korea
          • 5.2.7.2.5. Taiwan
          • 5.2.7.2.6. Australia
          • 5.2.7.2.7. Rest of Asia-Pacific
        • 5.2.7.3. Europe
          • 5.2.7.3.1. Germany
          • 5.2.7.3.2. France
          • 5.2.7.3.3. Italy
          • 5.2.7.3.4. United Kingdom
          • 5.2.7.3.5. Netherlands
          • 5.2.7.3.6. Rest of Europe
        • 5.2.7.4. MEA
          • 5.2.7.4.1. Middle East
          • 5.2.7.4.2. Africa
        • 5.2.7.5. North America
          • 5.2.7.5.1. United States
          • 5.2.7.5.2. Canada
          • 5.2.7.5.3. Mexico
  • 6. Digital Biology: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. DUNA Bioinformatics (Brazil)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Precigen (Intrexon Corporation) (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Dassault Systèmes (France)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Genedata AG (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Simulations Plus, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
  • 7. Global Digital Biology Sale, by Type, Application, Drug Discovery & Disease Modelling, Preclinical Drug Development, Platform, Clinical trials and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Digital Biology (Value)
      • 7.2.1. Global Digital Biology by: Type (Value)
        • 7.2.1.1. Botany,
        • 7.2.1.2. Conservation
        • 7.2.1.3. , ecology,
        • 7.2.1.4. Evolution,
        • 7.2.1.5. Genetics,
        • 7.2.1.6. Marine biology
        • 7.2.1.7. , medicine,
        • 7.2.1.8. Microbiology, molecular biology, physiology, and zoology.
      • 7.2.2. Global Digital Biology by: Application (Value)
        • 7.2.2.1. Anatomy
        • 7.2.2.2. Associated fields
      • 7.2.3. Global Digital Biology by: Drug Discovery & Disease Modelling (Value)
        • 7.2.3.1. Target Identification
        • 7.2.3.2. Target Validation
        • 7.2.3.3. Lead Optimization
        • 7.2.3.4. Others
      • 7.2.4. Global Digital Biology by: Preclinical Drug Development (Value)
        • 7.2.4.1. Pharmacokinetics
        • 7.2.4.2. Pharmacodynamics
      • 7.2.5. Global Digital Biology by: Platform (Value)
        • 7.2.5.1. Open Source
        • 7.2.5.2. Closed Source
      • 7.2.6. Global Digital Biology by: Clinical trials (Value)
        • 7.2.6.1. Phase I
        • 7.2.6.2. Phase II
        • 7.2.6.3. Phase III
        • 7.2.6.4. Human Body Simulation Software
      • 7.2.7. Global Digital Biology Region
        • 7.2.7.1. South America
          • 7.2.7.1.1. Brazil
          • 7.2.7.1.2. Argentina
          • 7.2.7.1.3. Rest of South America
        • 7.2.7.2. Asia Pacific
          • 7.2.7.2.1. China
          • 7.2.7.2.2. Japan
          • 7.2.7.2.3. India
          • 7.2.7.2.4. South Korea
          • 7.2.7.2.5. Taiwan
          • 7.2.7.2.6. Australia
          • 7.2.7.2.7. Rest of Asia-Pacific
        • 7.2.7.3. Europe
          • 7.2.7.3.1. Germany
          • 7.2.7.3.2. France
          • 7.2.7.3.3. Italy
          • 7.2.7.3.4. United Kingdom
          • 7.2.7.3.5. Netherlands
          • 7.2.7.3.6. Rest of Europe
        • 7.2.7.4. MEA
          • 7.2.7.4.1. Middle East
          • 7.2.7.4.2. Africa
        • 7.2.7.5. North America
          • 7.2.7.5.1. United States
          • 7.2.7.5.2. Canada
          • 7.2.7.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Digital Biology: by Type(USD Million)
  • Table 2. Digital Biology Botany, , by Region USD Million (2017-2022)
  • Table 3. Digital Biology Conservation , by Region USD Million (2017-2022)
  • Table 4. Digital Biology , ecology, , by Region USD Million (2017-2022)
  • Table 5. Digital Biology Evolution, , by Region USD Million (2017-2022)
  • Table 6. Digital Biology Genetics, , by Region USD Million (2017-2022)
  • Table 7. Digital Biology Marine biology , by Region USD Million (2017-2022)
  • Table 8. Digital Biology , medicine, , by Region USD Million (2017-2022)
  • Table 9. Digital Biology Microbiology, molecular biology, physiology, and zoology. , by Region USD Million (2017-2022)
  • Table 10. Digital Biology: by Application(USD Million)
  • Table 11. Digital Biology Anatomy , by Region USD Million (2017-2022)
  • Table 12. Digital Biology Associated fields , by Region USD Million (2017-2022)
  • Table 13. Digital Biology: by Drug Discovery & Disease Modelling(USD Million)
  • Table 14. Digital Biology Target Identification , by Region USD Million (2017-2022)
  • Table 15. Digital Biology Target Validation , by Region USD Million (2017-2022)
  • Table 16. Digital Biology Lead Optimization , by Region USD Million (2017-2022)
  • Table 17. Digital Biology Others , by Region USD Million (2017-2022)
  • Table 18. Digital Biology: by Preclinical Drug Development(USD Million)
  • Table 19. Digital Biology Pharmacokinetics , by Region USD Million (2017-2022)
  • Table 20. Digital Biology Pharmacodynamics , by Region USD Million (2017-2022)
  • Table 21. Digital Biology: by Platform(USD Million)
  • Table 22. Digital Biology Open Source , by Region USD Million (2017-2022)
  • Table 23. Digital Biology Closed Source , by Region USD Million (2017-2022)
  • Table 24. Digital Biology: by Clinical trials(USD Million)
  • Table 25. Digital Biology Phase I , by Region USD Million (2017-2022)
  • Table 26. Digital Biology Phase II , by Region USD Million (2017-2022)
  • Table 27. Digital Biology Phase III , by Region USD Million (2017-2022)
  • Table 28. Digital Biology Human Body Simulation Software , by Region USD Million (2017-2022)
  • Table 29. South America Digital Biology, by Country USD Million (2017-2022)
  • Table 30. South America Digital Biology, by Type USD Million (2017-2022)
  • Table 31. South America Digital Biology, by Application USD Million (2017-2022)
  • Table 32. South America Digital Biology, by Drug Discovery & Disease Modelling USD Million (2017-2022)
  • Table 33. South America Digital Biology, by Preclinical Drug Development USD Million (2017-2022)
  • Table 34. South America Digital Biology, by Platform USD Million (2017-2022)
  • Table 35. South America Digital Biology, by Clinical trials USD Million (2017-2022)
  • Table 36. Brazil Digital Biology, by Type USD Million (2017-2022)
  • Table 37. Brazil Digital Biology, by Application USD Million (2017-2022)
  • Table 38. Brazil Digital Biology, by Drug Discovery & Disease Modelling USD Million (2017-2022)
  • Table 39. Brazil Digital Biology, by Preclinical Drug Development USD Million (2017-2022)
  • Table 40. Brazil Digital Biology, by Platform USD Million (2017-2022)
  • Table 41. Brazil Digital Biology, by Clinical trials USD Million (2017-2022)
  • Table 42. Argentina Digital Biology, by Type USD Million (2017-2022)
  • Table 43. Argentina Digital Biology, by Application USD Million (2017-2022)
  • Table 44. Argentina Digital Biology, by Drug Discovery & Disease Modelling USD Million (2017-2022)
  • Table 45. Argentina Digital Biology, by Preclinical Drug Development USD Million (2017-2022)
  • Table 46. Argentina Digital Biology, by Platform USD Million (2017-2022)
  • Table 47. Argentina Digital Biology, by Clinical trials USD Million (2017-2022)
  • Table 48. Rest of South America Digital Biology, by Type USD Million (2017-2022)
  • Table 49. Rest of South America Digital Biology, by Application USD Million (2017-2022)
  • Table 50. Rest of South America Digital Biology, by Drug Discovery & Disease Modelling USD Million (2017-2022)
  • Table 51. Rest of South America Digital Biology, by Preclinical Drug Development USD Million (2017-2022)
  • Table 52. Rest of South America Digital Biology, by Platform USD Million (2017-2022)
  • Table 53. Rest of South America Digital Biology, by Clinical trials USD Million (2017-2022)
  • Table 54. Asia Pacific Digital Biology, by Country USD Million (2017-2022)
  • Table 55. Asia Pacific Digital Biology, by Type USD Million (2017-2022)
  • Table 56. Asia Pacific Digital Biology, by Application USD Million (2017-2022)
  • Table 57. Asia Pacific Digital Biology, by Drug Discovery & Disease Modelling USD Million (2017-2022)
  • Table 58. Asia Pacific Digital Biology, by Preclinical Drug Development USD Million (2017-2022)
  • Table 59. Asia Pacific Digital Biology, by Platform USD Million (2017-2022)
  • Table 60. Asia Pacific Digital Biology, by Clinical trials USD Million (2017-2022)
  • Table 61. China Digital Biology, by Type USD Million (2017-2022)
  • Table 62. China Digital Biology, by Application USD Million (2017-2022)
  • Table 63. China Digital Biology, by Drug Discovery & Disease Modelling USD Million (2017-2022)
  • Table 64. China Digital Biology, by Preclinical Drug Development USD Million (2017-2022)
  • Table 65. China Digital Biology, by Platform USD Million (2017-2022)
  • Table 66. China Digital Biology, by Clinical trials USD Million (2017-2022)
  • Table 67. Japan Digital Biology, by Type USD Million (2017-2022)
  • Table 68. Japan Digital Biology, by Application USD Million (2017-2022)
  • Table 69. Japan Digital Biology, by Drug Discovery & Disease Modelling USD Million (2017-2022)
  • Table 70. Japan Digital Biology, by Preclinical Drug Development USD Million (2017-2022)
  • Table 71. Japan Digital Biology, by Platform USD Million (2017-2022)
  • Table 72. Japan Digital Biology, by Clinical trials USD Million (2017-2022)
  • Table 73. India Digital Biology, by Type USD Million (2017-2022)
  • Table 74. India Digital Biology, by Application USD Million (2017-2022)
  • Table 75. India Digital Biology, by Drug Discovery & Disease Modelling USD Million (2017-2022)
  • Table 76. India Digital Biology, by Preclinical Drug Development USD Million (2017-2022)
  • Table 77. India Digital Biology, by Platform USD Million (2017-2022)
  • Table 78. India Digital Biology, by Clinical trials USD Million (2017-2022)
  • Table 79. South Korea Digital Biology, by Type USD Million (2017-2022)
  • Table 80. South Korea Digital Biology, by Application USD Million (2017-2022)
  • Table 81. South Korea Digital Biology, by Drug Discovery & Disease Modelling USD Million (2017-2022)
  • Table 82. South Korea Digital Biology, by Preclinical Drug Development USD Million (2017-2022)
  • Table 83. South Korea Digital Biology, by Platform USD Million (2017-2022)
  • Table 84. South Korea Digital Biology, by Clinical trials USD Million (2017-2022)
  • Table 85. Taiwan Digital Biology, by Type USD Million (2017-2022)
  • Table 86. Taiwan Digital Biology, by Application USD Million (2017-2022)
  • Table 87. Taiwan Digital Biology, by Drug Discovery & Disease Modelling USD Million (2017-2022)
  • Table 88. Taiwan Digital Biology, by Preclinical Drug Development USD Million (2017-2022)
  • Table 89. Taiwan Digital Biology, by Platform USD Million (2017-2022)
  • Table 90. Taiwan Digital Biology, by Clinical trials USD Million (2017-2022)
  • Table 91. Australia Digital Biology, by Type USD Million (2017-2022)
  • Table 92. Australia Digital Biology, by Application USD Million (2017-2022)
  • Table 93. Australia Digital Biology, by Drug Discovery & Disease Modelling USD Million (2017-2022)
  • Table 94. Australia Digital Biology, by Preclinical Drug Development USD Million (2017-2022)
  • Table 95. Australia Digital Biology, by Platform USD Million (2017-2022)
  • Table 96. Australia Digital Biology, by Clinical trials USD Million (2017-2022)
  • Table 97. Rest of Asia-Pacific Digital Biology, by Type USD Million (2017-2022)
  • Table 98. Rest of Asia-Pacific Digital Biology, by Application USD Million (2017-2022)
  • Table 99. Rest of Asia-Pacific Digital Biology, by Drug Discovery & Disease Modelling USD Million (2017-2022)
  • Table 100. Rest of Asia-Pacific Digital Biology, by Preclinical Drug Development USD Million (2017-2022)
  • Table 101. Rest of Asia-Pacific Digital Biology, by Platform USD Million (2017-2022)
  • Table 102. Rest of Asia-Pacific Digital Biology, by Clinical trials USD Million (2017-2022)
  • Table 103. Europe Digital Biology, by Country USD Million (2017-2022)
  • Table 104. Europe Digital Biology, by Type USD Million (2017-2022)
  • Table 105. Europe Digital Biology, by Application USD Million (2017-2022)
  • Table 106. Europe Digital Biology, by Drug Discovery & Disease Modelling USD Million (2017-2022)
  • Table 107. Europe Digital Biology, by Preclinical Drug Development USD Million (2017-2022)
  • Table 108. Europe Digital Biology, by Platform USD Million (2017-2022)
  • Table 109. Europe Digital Biology, by Clinical trials USD Million (2017-2022)
  • Table 110. Germany Digital Biology, by Type USD Million (2017-2022)
  • Table 111. Germany Digital Biology, by Application USD Million (2017-2022)
  • Table 112. Germany Digital Biology, by Drug Discovery & Disease Modelling USD Million (2017-2022)
  • Table 113. Germany Digital Biology, by Preclinical Drug Development USD Million (2017-2022)
  • Table 114. Germany Digital Biology, by Platform USD Million (2017-2022)
  • Table 115. Germany Digital Biology, by Clinical trials USD Million (2017-2022)
  • Table 116. France Digital Biology, by Type USD Million (2017-2022)
  • Table 117. France Digital Biology, by Application USD Million (2017-2022)
  • Table 118. France Digital Biology, by Drug Discovery & Disease Modelling USD Million (2017-2022)
  • Table 119. France Digital Biology, by Preclinical Drug Development USD Million (2017-2022)
  • Table 120. France Digital Biology, by Platform USD Million (2017-2022)
  • Table 121. France Digital Biology, by Clinical trials USD Million (2017-2022)
  • Table 122. Italy Digital Biology, by Type USD Million (2017-2022)
  • Table 123. Italy Digital Biology, by Application USD Million (2017-2022)
  • Table 124. Italy Digital Biology, by Drug Discovery & Disease Modelling USD Million (2017-2022)
  • Table 125. Italy Digital Biology, by Preclinical Drug Development USD Million (2017-2022)
  • Table 126. Italy Digital Biology, by Platform USD Million (2017-2022)
  • Table 127. Italy Digital Biology, by Clinical trials USD Million (2017-2022)
  • Table 128. United Kingdom Digital Biology, by Type USD Million (2017-2022)
  • Table 129. United Kingdom Digital Biology, by Application USD Million (2017-2022)
  • Table 130. United Kingdom Digital Biology, by Drug Discovery & Disease Modelling USD Million (2017-2022)
  • Table 131. United Kingdom Digital Biology, by Preclinical Drug Development USD Million (2017-2022)
  • Table 132. United Kingdom Digital Biology, by Platform USD Million (2017-2022)
  • Table 133. United Kingdom Digital Biology, by Clinical trials USD Million (2017-2022)
  • Table 134. Netherlands Digital Biology, by Type USD Million (2017-2022)
  • Table 135. Netherlands Digital Biology, by Application USD Million (2017-2022)
  • Table 136. Netherlands Digital Biology, by Drug Discovery & Disease Modelling USD Million (2017-2022)
  • Table 137. Netherlands Digital Biology, by Preclinical Drug Development USD Million (2017-2022)
  • Table 138. Netherlands Digital Biology, by Platform USD Million (2017-2022)
  • Table 139. Netherlands Digital Biology, by Clinical trials USD Million (2017-2022)
  • Table 140. Rest of Europe Digital Biology, by Type USD Million (2017-2022)
  • Table 141. Rest of Europe Digital Biology, by Application USD Million (2017-2022)
  • Table 142. Rest of Europe Digital Biology, by Drug Discovery & Disease Modelling USD Million (2017-2022)
  • Table 143. Rest of Europe Digital Biology, by Preclinical Drug Development USD Million (2017-2022)
  • Table 144. Rest of Europe Digital Biology, by Platform USD Million (2017-2022)
  • Table 145. Rest of Europe Digital Biology, by Clinical trials USD Million (2017-2022)
  • Table 146. MEA Digital Biology, by Country USD Million (2017-2022)
  • Table 147. MEA Digital Biology, by Type USD Million (2017-2022)
  • Table 148. MEA Digital Biology, by Application USD Million (2017-2022)
  • Table 149. MEA Digital Biology, by Drug Discovery & Disease Modelling USD Million (2017-2022)
  • Table 150. MEA Digital Biology, by Preclinical Drug Development USD Million (2017-2022)
  • Table 151. MEA Digital Biology, by Platform USD Million (2017-2022)
  • Table 152. MEA Digital Biology, by Clinical trials USD Million (2017-2022)
  • Table 153. Middle East Digital Biology, by Type USD Million (2017-2022)
  • Table 154. Middle East Digital Biology, by Application USD Million (2017-2022)
  • Table 155. Middle East Digital Biology, by Drug Discovery & Disease Modelling USD Million (2017-2022)
  • Table 156. Middle East Digital Biology, by Preclinical Drug Development USD Million (2017-2022)
  • Table 157. Middle East Digital Biology, by Platform USD Million (2017-2022)
  • Table 158. Middle East Digital Biology, by Clinical trials USD Million (2017-2022)
  • Table 159. Africa Digital Biology, by Type USD Million (2017-2022)
  • Table 160. Africa Digital Biology, by Application USD Million (2017-2022)
  • Table 161. Africa Digital Biology, by Drug Discovery & Disease Modelling USD Million (2017-2022)
  • Table 162. Africa Digital Biology, by Preclinical Drug Development USD Million (2017-2022)
  • Table 163. Africa Digital Biology, by Platform USD Million (2017-2022)
  • Table 164. Africa Digital Biology, by Clinical trials USD Million (2017-2022)
  • Table 165. North America Digital Biology, by Country USD Million (2017-2022)
  • Table 166. North America Digital Biology, by Type USD Million (2017-2022)
  • Table 167. North America Digital Biology, by Application USD Million (2017-2022)
  • Table 168. North America Digital Biology, by Drug Discovery & Disease Modelling USD Million (2017-2022)
  • Table 169. North America Digital Biology, by Preclinical Drug Development USD Million (2017-2022)
  • Table 170. North America Digital Biology, by Platform USD Million (2017-2022)
  • Table 171. North America Digital Biology, by Clinical trials USD Million (2017-2022)
  • Table 172. United States Digital Biology, by Type USD Million (2017-2022)
  • Table 173. United States Digital Biology, by Application USD Million (2017-2022)
  • Table 174. United States Digital Biology, by Drug Discovery & Disease Modelling USD Million (2017-2022)
  • Table 175. United States Digital Biology, by Preclinical Drug Development USD Million (2017-2022)
  • Table 176. United States Digital Biology, by Platform USD Million (2017-2022)
  • Table 177. United States Digital Biology, by Clinical trials USD Million (2017-2022)
  • Table 178. Canada Digital Biology, by Type USD Million (2017-2022)
  • Table 179. Canada Digital Biology, by Application USD Million (2017-2022)
  • Table 180. Canada Digital Biology, by Drug Discovery & Disease Modelling USD Million (2017-2022)
  • Table 181. Canada Digital Biology, by Preclinical Drug Development USD Million (2017-2022)
  • Table 182. Canada Digital Biology, by Platform USD Million (2017-2022)
  • Table 183. Canada Digital Biology, by Clinical trials USD Million (2017-2022)
  • Table 184. Mexico Digital Biology, by Type USD Million (2017-2022)
  • Table 185. Mexico Digital Biology, by Application USD Million (2017-2022)
  • Table 186. Mexico Digital Biology, by Drug Discovery & Disease Modelling USD Million (2017-2022)
  • Table 187. Mexico Digital Biology, by Preclinical Drug Development USD Million (2017-2022)
  • Table 188. Mexico Digital Biology, by Platform USD Million (2017-2022)
  • Table 189. Mexico Digital Biology, by Clinical trials USD Million (2017-2022)
  • Table 190. Company Basic Information, Sales Area and Its Competitors
  • Table 191. Company Basic Information, Sales Area and Its Competitors
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Digital Biology: by Type(USD Million)
  • Table 196. Digital Biology Botany, , by Region USD Million (2023-2028)
  • Table 197. Digital Biology Conservation , by Region USD Million (2023-2028)
  • Table 198. Digital Biology , ecology, , by Region USD Million (2023-2028)
  • Table 199. Digital Biology Evolution, , by Region USD Million (2023-2028)
  • Table 200. Digital Biology Genetics, , by Region USD Million (2023-2028)
  • Table 201. Digital Biology Marine biology , by Region USD Million (2023-2028)
  • Table 202. Digital Biology , medicine, , by Region USD Million (2023-2028)
  • Table 203. Digital Biology Microbiology, molecular biology, physiology, and zoology. , by Region USD Million (2023-2028)
  • Table 204. Digital Biology: by Application(USD Million)
  • Table 205. Digital Biology Anatomy , by Region USD Million (2023-2028)
  • Table 206. Digital Biology Associated fields , by Region USD Million (2023-2028)
  • Table 207. Digital Biology: by Drug Discovery & Disease Modelling(USD Million)
  • Table 208. Digital Biology Target Identification , by Region USD Million (2023-2028)
  • Table 209. Digital Biology Target Validation , by Region USD Million (2023-2028)
  • Table 210. Digital Biology Lead Optimization , by Region USD Million (2023-2028)
  • Table 211. Digital Biology Others , by Region USD Million (2023-2028)
  • Table 212. Digital Biology: by Preclinical Drug Development(USD Million)
  • Table 213. Digital Biology Pharmacokinetics , by Region USD Million (2023-2028)
  • Table 214. Digital Biology Pharmacodynamics , by Region USD Million (2023-2028)
  • Table 215. Digital Biology: by Platform(USD Million)
  • Table 216. Digital Biology Open Source , by Region USD Million (2023-2028)
  • Table 217. Digital Biology Closed Source , by Region USD Million (2023-2028)
  • Table 218. Digital Biology: by Clinical trials(USD Million)
  • Table 219. Digital Biology Phase I , by Region USD Million (2023-2028)
  • Table 220. Digital Biology Phase II , by Region USD Million (2023-2028)
  • Table 221. Digital Biology Phase III , by Region USD Million (2023-2028)
  • Table 222. Digital Biology Human Body Simulation Software , by Region USD Million (2023-2028)
  • Table 223. South America Digital Biology, by Country USD Million (2023-2028)
  • Table 224. South America Digital Biology, by Type USD Million (2023-2028)
  • Table 225. South America Digital Biology, by Application USD Million (2023-2028)
  • Table 226. South America Digital Biology, by Drug Discovery & Disease Modelling USD Million (2023-2028)
  • Table 227. South America Digital Biology, by Preclinical Drug Development USD Million (2023-2028)
  • Table 228. South America Digital Biology, by Platform USD Million (2023-2028)
  • Table 229. South America Digital Biology, by Clinical trials USD Million (2023-2028)
  • Table 230. Brazil Digital Biology, by Type USD Million (2023-2028)
  • Table 231. Brazil Digital Biology, by Application USD Million (2023-2028)
  • Table 232. Brazil Digital Biology, by Drug Discovery & Disease Modelling USD Million (2023-2028)
  • Table 233. Brazil Digital Biology, by Preclinical Drug Development USD Million (2023-2028)
  • Table 234. Brazil Digital Biology, by Platform USD Million (2023-2028)
  • Table 235. Brazil Digital Biology, by Clinical trials USD Million (2023-2028)
  • Table 236. Argentina Digital Biology, by Type USD Million (2023-2028)
  • Table 237. Argentina Digital Biology, by Application USD Million (2023-2028)
  • Table 238. Argentina Digital Biology, by Drug Discovery & Disease Modelling USD Million (2023-2028)
  • Table 239. Argentina Digital Biology, by Preclinical Drug Development USD Million (2023-2028)
  • Table 240. Argentina Digital Biology, by Platform USD Million (2023-2028)
  • Table 241. Argentina Digital Biology, by Clinical trials USD Million (2023-2028)
  • Table 242. Rest of South America Digital Biology, by Type USD Million (2023-2028)
  • Table 243. Rest of South America Digital Biology, by Application USD Million (2023-2028)
  • Table 244. Rest of South America Digital Biology, by Drug Discovery & Disease Modelling USD Million (2023-2028)
  • Table 245. Rest of South America Digital Biology, by Preclinical Drug Development USD Million (2023-2028)
  • Table 246. Rest of South America Digital Biology, by Platform USD Million (2023-2028)
  • Table 247. Rest of South America Digital Biology, by Clinical trials USD Million (2023-2028)
  • Table 248. Asia Pacific Digital Biology, by Country USD Million (2023-2028)
  • Table 249. Asia Pacific Digital Biology, by Type USD Million (2023-2028)
  • Table 250. Asia Pacific Digital Biology, by Application USD Million (2023-2028)
  • Table 251. Asia Pacific Digital Biology, by Drug Discovery & Disease Modelling USD Million (2023-2028)
  • Table 252. Asia Pacific Digital Biology, by Preclinical Drug Development USD Million (2023-2028)
  • Table 253. Asia Pacific Digital Biology, by Platform USD Million (2023-2028)
  • Table 254. Asia Pacific Digital Biology, by Clinical trials USD Million (2023-2028)
  • Table 255. China Digital Biology, by Type USD Million (2023-2028)
  • Table 256. China Digital Biology, by Application USD Million (2023-2028)
  • Table 257. China Digital Biology, by Drug Discovery & Disease Modelling USD Million (2023-2028)
  • Table 258. China Digital Biology, by Preclinical Drug Development USD Million (2023-2028)
  • Table 259. China Digital Biology, by Platform USD Million (2023-2028)
  • Table 260. China Digital Biology, by Clinical trials USD Million (2023-2028)
  • Table 261. Japan Digital Biology, by Type USD Million (2023-2028)
  • Table 262. Japan Digital Biology, by Application USD Million (2023-2028)
  • Table 263. Japan Digital Biology, by Drug Discovery & Disease Modelling USD Million (2023-2028)
  • Table 264. Japan Digital Biology, by Preclinical Drug Development USD Million (2023-2028)
  • Table 265. Japan Digital Biology, by Platform USD Million (2023-2028)
  • Table 266. Japan Digital Biology, by Clinical trials USD Million (2023-2028)
  • Table 267. India Digital Biology, by Type USD Million (2023-2028)
  • Table 268. India Digital Biology, by Application USD Million (2023-2028)
  • Table 269. India Digital Biology, by Drug Discovery & Disease Modelling USD Million (2023-2028)
  • Table 270. India Digital Biology, by Preclinical Drug Development USD Million (2023-2028)
  • Table 271. India Digital Biology, by Platform USD Million (2023-2028)
  • Table 272. India Digital Biology, by Clinical trials USD Million (2023-2028)
  • Table 273. South Korea Digital Biology, by Type USD Million (2023-2028)
  • Table 274. South Korea Digital Biology, by Application USD Million (2023-2028)
  • Table 275. South Korea Digital Biology, by Drug Discovery & Disease Modelling USD Million (2023-2028)
  • Table 276. South Korea Digital Biology, by Preclinical Drug Development USD Million (2023-2028)
  • Table 277. South Korea Digital Biology, by Platform USD Million (2023-2028)
  • Table 278. South Korea Digital Biology, by Clinical trials USD Million (2023-2028)
  • Table 279. Taiwan Digital Biology, by Type USD Million (2023-2028)
  • Table 280. Taiwan Digital Biology, by Application USD Million (2023-2028)
  • Table 281. Taiwan Digital Biology, by Drug Discovery & Disease Modelling USD Million (2023-2028)
  • Table 282. Taiwan Digital Biology, by Preclinical Drug Development USD Million (2023-2028)
  • Table 283. Taiwan Digital Biology, by Platform USD Million (2023-2028)
  • Table 284. Taiwan Digital Biology, by Clinical trials USD Million (2023-2028)
  • Table 285. Australia Digital Biology, by Type USD Million (2023-2028)
  • Table 286. Australia Digital Biology, by Application USD Million (2023-2028)
  • Table 287. Australia Digital Biology, by Drug Discovery & Disease Modelling USD Million (2023-2028)
  • Table 288. Australia Digital Biology, by Preclinical Drug Development USD Million (2023-2028)
  • Table 289. Australia Digital Biology, by Platform USD Million (2023-2028)
  • Table 290. Australia Digital Biology, by Clinical trials USD Million (2023-2028)
  • Table 291. Rest of Asia-Pacific Digital Biology, by Type USD Million (2023-2028)
  • Table 292. Rest of Asia-Pacific Digital Biology, by Application USD Million (2023-2028)
  • Table 293. Rest of Asia-Pacific Digital Biology, by Drug Discovery & Disease Modelling USD Million (2023-2028)
  • Table 294. Rest of Asia-Pacific Digital Biology, by Preclinical Drug Development USD Million (2023-2028)
  • Table 295. Rest of Asia-Pacific Digital Biology, by Platform USD Million (2023-2028)
  • Table 296. Rest of Asia-Pacific Digital Biology, by Clinical trials USD Million (2023-2028)
  • Table 297. Europe Digital Biology, by Country USD Million (2023-2028)
  • Table 298. Europe Digital Biology, by Type USD Million (2023-2028)
  • Table 299. Europe Digital Biology, by Application USD Million (2023-2028)
  • Table 300. Europe Digital Biology, by Drug Discovery & Disease Modelling USD Million (2023-2028)
  • Table 301. Europe Digital Biology, by Preclinical Drug Development USD Million (2023-2028)
  • Table 302. Europe Digital Biology, by Platform USD Million (2023-2028)
  • Table 303. Europe Digital Biology, by Clinical trials USD Million (2023-2028)
  • Table 304. Germany Digital Biology, by Type USD Million (2023-2028)
  • Table 305. Germany Digital Biology, by Application USD Million (2023-2028)
  • Table 306. Germany Digital Biology, by Drug Discovery & Disease Modelling USD Million (2023-2028)
  • Table 307. Germany Digital Biology, by Preclinical Drug Development USD Million (2023-2028)
  • Table 308. Germany Digital Biology, by Platform USD Million (2023-2028)
  • Table 309. Germany Digital Biology, by Clinical trials USD Million (2023-2028)
  • Table 310. France Digital Biology, by Type USD Million (2023-2028)
  • Table 311. France Digital Biology, by Application USD Million (2023-2028)
  • Table 312. France Digital Biology, by Drug Discovery & Disease Modelling USD Million (2023-2028)
  • Table 313. France Digital Biology, by Preclinical Drug Development USD Million (2023-2028)
  • Table 314. France Digital Biology, by Platform USD Million (2023-2028)
  • Table 315. France Digital Biology, by Clinical trials USD Million (2023-2028)
  • Table 316. Italy Digital Biology, by Type USD Million (2023-2028)
  • Table 317. Italy Digital Biology, by Application USD Million (2023-2028)
  • Table 318. Italy Digital Biology, by Drug Discovery & Disease Modelling USD Million (2023-2028)
  • Table 319. Italy Digital Biology, by Preclinical Drug Development USD Million (2023-2028)
  • Table 320. Italy Digital Biology, by Platform USD Million (2023-2028)
  • Table 321. Italy Digital Biology, by Clinical trials USD Million (2023-2028)
  • Table 322. United Kingdom Digital Biology, by Type USD Million (2023-2028)
  • Table 323. United Kingdom Digital Biology, by Application USD Million (2023-2028)
  • Table 324. United Kingdom Digital Biology, by Drug Discovery & Disease Modelling USD Million (2023-2028)
  • Table 325. United Kingdom Digital Biology, by Preclinical Drug Development USD Million (2023-2028)
  • Table 326. United Kingdom Digital Biology, by Platform USD Million (2023-2028)
  • Table 327. United Kingdom Digital Biology, by Clinical trials USD Million (2023-2028)
  • Table 328. Netherlands Digital Biology, by Type USD Million (2023-2028)
  • Table 329. Netherlands Digital Biology, by Application USD Million (2023-2028)
  • Table 330. Netherlands Digital Biology, by Drug Discovery & Disease Modelling USD Million (2023-2028)
  • Table 331. Netherlands Digital Biology, by Preclinical Drug Development USD Million (2023-2028)
  • Table 332. Netherlands Digital Biology, by Platform USD Million (2023-2028)
  • Table 333. Netherlands Digital Biology, by Clinical trials USD Million (2023-2028)
  • Table 334. Rest of Europe Digital Biology, by Type USD Million (2023-2028)
  • Table 335. Rest of Europe Digital Biology, by Application USD Million (2023-2028)
  • Table 336. Rest of Europe Digital Biology, by Drug Discovery & Disease Modelling USD Million (2023-2028)
  • Table 337. Rest of Europe Digital Biology, by Preclinical Drug Development USD Million (2023-2028)
  • Table 338. Rest of Europe Digital Biology, by Platform USD Million (2023-2028)
  • Table 339. Rest of Europe Digital Biology, by Clinical trials USD Million (2023-2028)
  • Table 340. MEA Digital Biology, by Country USD Million (2023-2028)
  • Table 341. MEA Digital Biology, by Type USD Million (2023-2028)
  • Table 342. MEA Digital Biology, by Application USD Million (2023-2028)
  • Table 343. MEA Digital Biology, by Drug Discovery & Disease Modelling USD Million (2023-2028)
  • Table 344. MEA Digital Biology, by Preclinical Drug Development USD Million (2023-2028)
  • Table 345. MEA Digital Biology, by Platform USD Million (2023-2028)
  • Table 346. MEA Digital Biology, by Clinical trials USD Million (2023-2028)
  • Table 347. Middle East Digital Biology, by Type USD Million (2023-2028)
  • Table 348. Middle East Digital Biology, by Application USD Million (2023-2028)
  • Table 349. Middle East Digital Biology, by Drug Discovery & Disease Modelling USD Million (2023-2028)
  • Table 350. Middle East Digital Biology, by Preclinical Drug Development USD Million (2023-2028)
  • Table 351. Middle East Digital Biology, by Platform USD Million (2023-2028)
  • Table 352. Middle East Digital Biology, by Clinical trials USD Million (2023-2028)
  • Table 353. Africa Digital Biology, by Type USD Million (2023-2028)
  • Table 354. Africa Digital Biology, by Application USD Million (2023-2028)
  • Table 355. Africa Digital Biology, by Drug Discovery & Disease Modelling USD Million (2023-2028)
  • Table 356. Africa Digital Biology, by Preclinical Drug Development USD Million (2023-2028)
  • Table 357. Africa Digital Biology, by Platform USD Million (2023-2028)
  • Table 358. Africa Digital Biology, by Clinical trials USD Million (2023-2028)
  • Table 359. North America Digital Biology, by Country USD Million (2023-2028)
  • Table 360. North America Digital Biology, by Type USD Million (2023-2028)
  • Table 361. North America Digital Biology, by Application USD Million (2023-2028)
  • Table 362. North America Digital Biology, by Drug Discovery & Disease Modelling USD Million (2023-2028)
  • Table 363. North America Digital Biology, by Preclinical Drug Development USD Million (2023-2028)
  • Table 364. North America Digital Biology, by Platform USD Million (2023-2028)
  • Table 365. North America Digital Biology, by Clinical trials USD Million (2023-2028)
  • Table 366. United States Digital Biology, by Type USD Million (2023-2028)
  • Table 367. United States Digital Biology, by Application USD Million (2023-2028)
  • Table 368. United States Digital Biology, by Drug Discovery & Disease Modelling USD Million (2023-2028)
  • Table 369. United States Digital Biology, by Preclinical Drug Development USD Million (2023-2028)
  • Table 370. United States Digital Biology, by Platform USD Million (2023-2028)
  • Table 371. United States Digital Biology, by Clinical trials USD Million (2023-2028)
  • Table 372. Canada Digital Biology, by Type USD Million (2023-2028)
  • Table 373. Canada Digital Biology, by Application USD Million (2023-2028)
  • Table 374. Canada Digital Biology, by Drug Discovery & Disease Modelling USD Million (2023-2028)
  • Table 375. Canada Digital Biology, by Preclinical Drug Development USD Million (2023-2028)
  • Table 376. Canada Digital Biology, by Platform USD Million (2023-2028)
  • Table 377. Canada Digital Biology, by Clinical trials USD Million (2023-2028)
  • Table 378. Mexico Digital Biology, by Type USD Million (2023-2028)
  • Table 379. Mexico Digital Biology, by Application USD Million (2023-2028)
  • Table 380. Mexico Digital Biology, by Drug Discovery & Disease Modelling USD Million (2023-2028)
  • Table 381. Mexico Digital Biology, by Preclinical Drug Development USD Million (2023-2028)
  • Table 382. Mexico Digital Biology, by Platform USD Million (2023-2028)
  • Table 383. Mexico Digital Biology, by Clinical trials USD Million (2023-2028)
  • Table 384. Research Programs/Design for This Report
  • Table 385. Key Data Information from Secondary Sources
  • Table 386. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Digital Biology: by Type USD Million (2017-2022)
  • Figure 5. Global Digital Biology: by Application USD Million (2017-2022)
  • Figure 6. Global Digital Biology: by Drug Discovery & Disease Modelling USD Million (2017-2022)
  • Figure 7. Global Digital Biology: by Preclinical Drug Development USD Million (2017-2022)
  • Figure 8. Global Digital Biology: by Platform USD Million (2017-2022)
  • Figure 9. Global Digital Biology: by Clinical trials USD Million (2017-2022)
  • Figure 10. South America Digital Biology Share (%), by Country
  • Figure 11. Asia Pacific Digital Biology Share (%), by Country
  • Figure 12. Europe Digital Biology Share (%), by Country
  • Figure 13. MEA Digital Biology Share (%), by Country
  • Figure 14. North America Digital Biology Share (%), by Country
  • Figure 15. Global Digital Biology share by Players 2022 (%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. DUNA Bioinformatics (Brazil) Revenue, Net Income and Gross profit
  • Figure 18. DUNA Bioinformatics (Brazil) Revenue: by Geography 2022
  • Figure 19. Precigen (Intrexon Corporation) (United States) Revenue, Net Income and Gross profit
  • Figure 20. Precigen (Intrexon Corporation) (United States) Revenue: by Geography 2022
  • Figure 21. Dassault Systèmes (France) Revenue, Net Income and Gross profit
  • Figure 22. Dassault Systèmes (France) Revenue: by Geography 2022
  • Figure 23. Genedata AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 24. Genedata AG (Switzerland) Revenue: by Geography 2022
  • Figure 25. Simulations Plus, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Simulations Plus, Inc. (United States) Revenue: by Geography 2022
  • Figure 27. Global Digital Biology: by Type USD Million (2023-2028)
  • Figure 28. Global Digital Biology: by Application USD Million (2023-2028)
  • Figure 29. Global Digital Biology: by Drug Discovery & Disease Modelling USD Million (2023-2028)
  • Figure 30. Global Digital Biology: by Preclinical Drug Development USD Million (2023-2028)
  • Figure 31. Global Digital Biology: by Platform USD Million (2023-2028)
  • Figure 32. Global Digital Biology: by Clinical trials USD Million (2023-2028)
  • Figure 33. South America Digital Biology Share (%), by Country
  • Figure 34. Asia Pacific Digital Biology Share (%), by Country
  • Figure 35. Europe Digital Biology Share (%), by Country
  • Figure 36. MEA Digital Biology Share (%), by Country
  • Figure 37. North America Digital Biology Share (%), by Country
List of companies from research coverage that are profiled in the study
  • DUNA Bioinformatics (Brazil)
  • Precigen (Intrexon Corporation) (United States)
  • Dassault Systèmes (France)
  • Genedata AG (Switzerland)
  • Simulations Plus, Inc. (United States)
Additional players considered in the study are as follows:
Genedata AG (Switzerland) , Simulations Plus, Inc. (United States)
Select User Access Type

Key Highlights of Report


Dec 2023 218 Pages 80 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Digital Biology Market Quantitative research analysis
Global Digital Biology Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Due to pricing constraints we only profile limited players in the study that includes a mix list of leaders and emerging players, however for evaluation of market size the coverage includes 100+ players.
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2028
The Study can be customized to meet your requirements. Please connect with our representative, in case you wish to add or remove certain country or profiled players.
  • Capital investment and huge data storage

Know More About Global Digital Biology Market Report?

Have a Query? Click Here

Other Related Reports

Robotic Hair Transplant Comprehensive Study by Type (Growing Eyebrows, Growing Eyelashes, Growing Back Hairline, Growing Hair, Others), End-users (Dermatology Clinics, Hospitals), Gender (Male, Femal...
$ 3500
Immunoprotein Diagnostic Testing Comprehensive Study by Type (C-reactive Protein Diagnostic Test, Complement System Protein Diagnostic Test, Pre-albumin Diagnostic Test, Haptoglobin Diagnostic Test, ...
$ 3750
Next Generation Cancer Diagnostic Comprehensive Study by Application (Biomarker Development, CTC Analysis, Proteomic Analysis, Epigenetic Analysis, Genetic Analysis), Function (Therapeutic Monitoring...
$ 3750
Wavefront LASIK Comprehensive Study by Type (Normal Wavefront, Aberrated Wavefront), Application (Eye Clinic, Hospital, Others), Technology (Wavefront-guided LASIK, Wavefront-optimized LASIK, Topogra...
$ 3450
Polymerase Chain Reaction Technologies Comprehensive Study by Type (Real-time PCR, Traditional PCR, Digital PCR), Application (Genetic Fingerprinting, Identification of Infectious Agents, Detection o...
$ 3750
Connected Patient Care Comprehensive Study by Type (M-Health Services, M-Health Devices, E-Prescription), Application (Monitoring, Diagnosis and Treatment, Education and Awareness, Healthcare Managem...
$ 3750